Literature DB >> 22328105

Up regulated complement and fc receptors in juvenile idiopathic arthritis and correlation with disease phenotype.

Kajsa E Prokopec1, Lillemor Berntson, Anders Öman, Sandra Kleinau.   

Abstract

PURPOSE: The progress in identifying immunological mechanisms in juvenile idiopathic arthritis (JIA) has partly been hampered by the fact that the disease is heterogeneous. Here we have investigated complement and Fc receptors, as part of the inflammatory process, in two subgroups of JIA.
METHODS: Blood from 26 patients with oligoarticular or polyarticular course type JIA and 21 healthy age and sex-matched controls were investigated by FACS and immunoassays.
RESULTS: Increased numbers of monocytes and augmented plasma levels of C-reactive protein, C3a and IgG were found in both JIA subgroups. However, only polyarticular patients exhibited increased expression of Fc gamma receptor (FcγR) II and III and complement receptor (CR) 1 on monocytes along with enhanced CR1 expression on B cells. A correlation was observed between degree of receptor expression and C3a levels in the patients.
CONCLUSIONS: Complement and Fc receptors are up regulated in children with multiple joint involvements, thus highlighting these pathways in the pathogenesis of polyarticular JIA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328105     DOI: 10.1007/s10875-012-9657-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

1.  Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.

Authors:  Thomas A Griffin; Michael G Barnes; Norman T Ilowite; Judyann C Olson; David D Sherry; Beth S Gottlieb; Bruce J Aronow; Paul Pavlidis; Claas H Hinze; Sherry Thornton; Susan D Thompson; Alexei A Grom; Robert A Colbert; David N Glass
Journal:  Arthritis Rheum       Date:  2009-07

2.  Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.

Authors:  J M Low; A K Chauhan; T L Moore
Journal:  Scand J Immunol       Date:  2007-01       Impact factor: 3.487

3.  Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis.

Authors:  T E Mollnes; A Paus
Journal:  Arthritis Rheum       Date:  1986-11

4.  Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.

Authors:  Marek Honczarenko; Mariusz Z Ratajczak; Anne Nicholson-Weller; Leslie E Silberstein
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

5.  Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids.

Authors:  I Torsteinsdóttir; N G Arvidson; R Hällgren; L Håkansson
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

6.  Complement receptor type 1 gene regulation: retinoic acid and cytosine arabinoside increase CR1 expression.

Authors:  T A Funkhouser; D P Vik
Journal:  Scand J Immunol       Date:  1999-01       Impact factor: 3.487

7.  Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria.

Authors:  Lillemor Berntson; Boel Andersson Gäre; Anders Fasth; Troels Herlin; Jon Kristinsson; Pekka Lahdenne; Gudmund Marhaug; Susan Nielsen; Pirkko Pelkonen; Marite Rygg
Journal:  J Rheumatol       Date:  2003-10       Impact factor: 4.666

8.  The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.

Authors:  D Bharadwaj; M P Stein; M Volzer; C Mold; T W Du Clos
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

9.  Structural recognition and functional activation of FcgammaR by innate pentraxins.

Authors:  Jinghua Lu; Lorraine L Marnell; Kristopher D Marjon; Carolyn Mold; Terry W Du Clos; Peter D Sun
Journal:  Nature       Date:  2008-11-16       Impact factor: 49.962

Review 10.  Complement Receptor 1: disease associations and therapeutic implications.

Authors:  Rohan Khera; Nibhriti Das
Journal:  Mol Immunol       Date:  2008-11-11       Impact factor: 4.407

View more
  5 in total

1.  Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Authors:  Katarzyna Kasperkiewicz; Łukasz Eppa; Anna S Świerzko; Marcin A Bartłomiejczyk; Zbigniew M Żuber; Katarzyna Siniewicz-Luzeńczyk; Elżbieta Mężyk; Misao Matsushita; Leokadia Bąk-Romaniszyn; Krzysztof Zeman; Mikael Skurnik; Maciej Cedzyński
Journal:  Immunol Cell Biol       Date:  2017-04-13       Impact factor: 5.126

2.  Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes.

Authors:  Grant S Schulert; Ndate Fall; John B Harley; Nan Shen; Daniel J Lovell; Sherry Thornton; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

Review 3.  Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.

Authors:  Katherine L Gill; Krishna K Machavaram; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

4.  Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE).

Authors:  Wei Jiang; Gary Gilkeson
Journal:  J Immunother Appl       Date:  2014-03-07

5.  Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort.

Authors:  Mia Glerup; Steffen Thiel; Veronika Rypdal; Ellen Dalen Arnstad; Maria Ekelund; Suvi Peltoniemi; Kristiina Aalto; Marite Rygg; Susan Nielsen; Anders Fasth; Lillemor Berntson; Ellen Nordal; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2019-09-09       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.